The PE Ratio as of December 2024 (TTM) for Werewolf Therapeutics, Inc. (HOWL) is -1.03

According to Werewolf Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.03. This represents a change of -58.43% compared to the average of -2.48 of the last 4 quarters.

Werewolf Therapeutics, Inc. (HOWL) Historical PE Ratio (quarterly & annually)

How has HOWL PE Ratio performed in the past?

The mean historical PE Ratio of Werewolf Therapeutics, Inc. over the last ten years is -16.85. The current -1.03 PE Ratio has changed 511.27% with respect to the historical average. Over the past ten years (40 quarters), HOWL's PE Ratio was at its highest in in the June 2020 quarter at 16.00. The PE Ratio was at its lowest in in the March 2021 quarter at -14.23.

Werewolf Therapeutics, Inc. (HOWL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Werewolf Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Werewolf Therapeutics, Inc. (HOWL) Average PE Ratio

How has HOWL PE Ratio performed in the past?

The current PE Ratio of Werewolf Therapeutics, Inc. (HOWL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Werewolf Therapeutics, Inc. (HOWL) PE Ratio vs. Peers

How is HOWL’s PE Ratio compared to its peers?

Werewolf Therapeutics, Inc.’s PE Ratio is greater than Monte Rosa Therapeutics, Inc. (-4.90), greater than Design Therapeutics, Inc. (-7.36), greater than Ikena Oncology, Inc. (-1.35), greater than Stoke Therapeutics, Inc. (-6.20), greater than Edgewise Therapeutics, Inc. (-22.63), greater than Decibel Therapeutics, Inc. (-1.95), greater than Celcuity Inc. (-5.65), greater than C4 Therapeutics, Inc. (-2.68), greater than Talaris Therapeutics, Inc. (-11.24), less than Adicet Bio, Inc. (-0.69), greater than Cullinan Oncology, Inc. (-4.82), less than Vor Biopharma Inc. (-0.53), greater than Third Harmonic Bio, Inc. (-11.38), less than Passage Bio, Inc. (-0.58), greater than Acrivon Therapeutics, Inc. Common Stock (-3.15), less than Eliem Therapeutics, Inc. (0), greater than Molecular Partners AG (-2.46), less than MediciNova, Inc. (-0.04), greater than Anebulo Pharmaceuticals, Inc. (-4.09), greater than Champions Oncology, Inc. (-184.36), greater than Cyteir Therapeutics, Inc. (-9.12),

Build a custom stock screener for Werewolf Therapeutics, Inc. (HOWL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Werewolf Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Werewolf Therapeutics, Inc. (HOWL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Werewolf Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.